4.4 Article

SGTA associates with intracellular aggregates in neurodegenerative diseases

期刊

MOLECULAR BRAIN
卷 14, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13041-021-00770-1

关键词

SGTA; Polyglutamine disease; Neurodegeneration; Intranuclear inclusion bodies; Multiple system atrophy

资金

  1. Japan Society for the Promotion of Science [18K07504, 18K07503, 19K07845, 20K16581, 18K07531, 19K17014, 18K07532]
  2. Health and Labor Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [201711060A]
  3. Takeda Science Foundation
  4. Strategic Research Promotion from Yokohama City University [SK2804]
  5. Grants-in-Aid for Scientific Research [18K07532, 18K07503, 19K17014, 19K07845, 20K16581, 18K07504, 18K07531] Funding Source: KAKEN

向作者/读者索取更多资源

The study identified small glutamine-rich tetratricopeptide repeat-containing protein alfa (SGTA) as an aggregate-interacting protein in neurodegenerative diseases. SGTA was found to interact with polyQ aggregates and reduce their accumulation, suggesting a potential role as a modifier in the molecular pathological mechanisms of various diseases.
Intracellular aggregates are a common pathological hallmark of neurodegenerative diseases such as polyglutamine (polyQ) diseases, amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and multiple system atrophy (MSA). Aggregates are mainly formed by aberrant disease-specific proteins and are accompanied by accumulation of other aggregate-interacting proteins. Although aggregate-interacting proteins have been considered to modulate the formation of aggregates and to be involved in molecular mechanisms of disease progression, the components of aggregate-interacting proteins remain unknown. In this study, we showed that small glutamine-rich tetratricopeptide repeat-containing protein alfa (SGTA) is an aggregate-interacting protein in neurodegenerative diseases. Immunohistochemistry showed that SGTA interacted with intracellular aggregates in Huntington disease (HD) cell models and neurons of HD model mice. We also revealed that SGTA colocalized with intracellular aggregates in postmortem brains of patients with polyQ diseases including spinocerebellar ataxia (SCA)1, SCA2, SCA3, and dentatorubral-pallidoluysian atrophy. In addition, SGTA colocalized with glial cytoplasmic inclusions in the brains of MSA patients, whereas no accumulation of SGTA was observed in neurons of PD and ALS patients. In vitro study showed that SGTA bound to polyQ aggregates through its C-terminal domain and SGTA overexpression reduced intracellular aggregates. These results suggest that SGTA may play a role in the formation of aggregates and may act as potential modifier of molecular pathological mechanisms of polyQ diseases and MSA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据